Lennar Investing Cash Flow increased by 103.3% to $93.36M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 334.4%, from $21.49M to $93.36M. Over 2 years (FY 2022 to FY 2025), Investing Cash Flow shows an upward trend with a 31.9% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$81.10M | -$19.99M | -$44.78M | -$66.70M | $0.00 | -$36.36M | -$44.22M | -$34.39M | -$62.02M | -$147.92M | -$126.87M | -$125.73M | $21.49M | $161.39M | $0.00 | $45.93M | $93.36M |
| QoQ Change | — | +75.3% | -124.0% | -49.0% | +100.0% | — | -21.6% | +22.2% | -80.3% | -138.5% | +14.2% | +0.9% | +117.1% | +651.0% | -100.0% | — | +103.3% |
| YoY Change | — | — | — | +17.8% | — | -81.8% | +1.2% | +48.4% | — | -306.9% | -186.9% | -102.7% | +114.5% | +227.2% | — | +136.5% | +334.4% |